VERACYTE, INC. Foreign Currency Transaction Gain (Loss), before Tax
VERACYTE, INC. (VCYT) reported Foreign Currency Transaction Gain (Loss), before Tax of $69.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-07-31
- VERACYTE, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$11.00K, a 100.32% decline year-over-year.
- VERACYTE, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $80.00K, a 94.95% decline year-over-year.
- VERACYTE, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$11.00K.
- VERACYTE, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$1.21M, a 171.68% decline year-over-year.
- VERACYTE, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $3.83M.
- VERACYTE, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$2.11M, a 292.52% decline from fiscal 2023.
- VERACYTE, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $1.10M.
- VERACYTE, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$522.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $69.00K 10-Q · filed 2026-07-31 | $58.00K derived: sum of 3 quarters · filed 2026-07-31 | -$1.15M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $80.00K 10-Q · filed 2026-05-06 | $69.00K derived: sum of 2 quarters · filed 2026-05-06 | -$1.14M derived: sum of 3 quarters · filed 2026-05-06 | $2.33M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.22M derived: sum of 2 quarters · filed 2026-02-26 | $2.25M derived: sum of 3 quarters · filed 2026-07-31 | $3.83M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.26M derived: sum of 2 quarters · filed 2026-07-31 | $3.85M 10-Q · filed 2025-11-05 | $950.00K derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $3.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $5.05M 10-Q · filed 2026-07-31 | $2.15M derived: sum of 3 quarters · filed 2026-07-31 | $3.84M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $1.58M 10-Q · filed 2026-05-06 | -$1.31M derived: sum of 2 quarters · filed 2026-05-06 | $371.00K derived: sum of 3 quarters · filed 2026-05-06 | $112.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.21M derived: sum of 2 quarters · filed 2026-02-26 | -$1.47M derived: sum of 3 quarters · filed 2026-02-26 | -$2.11M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.42M derived: sum of 2 quarters · filed 2025-11-05 | $785.00K 10-Q · filed 2025-11-05 | $2.54M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$259.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$896.00K 10-Q · filed 2025-08-07 | $857.00K derived: sum of 3 quarters · filed 2026-02-26 | $33.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$637.00K 10-Q · filed 2025-05-08 | $1.12M derived: sum of 2 quarters · filed 2026-02-26 | $292.00K derived: sum of 3 quarters · filed 2026-02-26 | $235.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $929.00K derived: sum of 2 quarters · filed 2026-02-26 | $872.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.10M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$824.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$881.00K derived: sum of 2 quarters · filed 2024-11-07 | -$657.00K 10-Q · filed 2024-11-07 | $384.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $167.00K 10-Q · filed 2024-08-07 | $1.21M derived: sum of 3 quarters · filed 2025-02-28 | $361.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $224.00K 10-Q · filed 2024-05-08 | $1.26M derived: sum of 2 quarters · filed 2025-02-28 | $418.00K derived: sum of 3 quarters · filed 2025-02-28 | -$167.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $194.00K derived: sum of 2 quarters · filed 2025-02-28 | -$391.00K derived: sum of 3 quarters · filed 2025-02-28 | -$522.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | -$847.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.43M derived: sum of 2 quarters · filed 2023-11-08 | -$1.56M 10-Q · filed 2023-11-08 | -$1.17M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$585.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$716.00K 10-Q · filed 2023-08-09 | -$326.00K derived: sum of 3 quarters · filed 2024-02-29 | -$61.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$131.00K 10-Q · filed 2023-05-05 | $259.00K derived: sum of 2 quarters · filed 2024-02-29 | $524.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.26M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $655.00K derived: sum of 2 quarters · filed 2024-02-29 | -$1.13M derived: sum of 3 quarters · filed 2024-02-29 | -$1.21M 10-K · filed 2024-02-29 |
| 2021-09-30 | $265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.52M derived: sum of 2 quarters · filed 2022-11-03 | -$1.60M 10-Q · filed 2022-11-03 | -$1.58M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$1.87M 10-Q · filed 2022-08-03 | -$1.85M derived: sum of 3 quarters · filed 2023-03-01 | -$1.83M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$82.00K 10-Q · filed 2022-05-04 | -$65.00K derived: sum of 2 quarters · filed 2023-03-01 | -$48.00K derived: sum of 3 quarters · filed 2023-03-01 | -$48.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $34.00K derived: sum of 2 quarters · filed 2023-03-01 | $34.00K derived: sum of 3 quarters · filed 2023-03-01 | $34.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $17.00K derived: sum of 2 quarters · filed 2021-11-09 | $17.00K 10-Q · filed 2021-11-09 | $17.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-02 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |